Functional PPAR-γ receptor is a novel therapeutic target for ACTH-secreting pituitary adenomas
Authors:
- Anthony P. HeaneyAHAnthony P. Heaney
- Manory FernandoMFManory Fernando
- William H. YongWYWilliam H. Yong
- Shlomo MelmedSMShlomo Melmed
- 15 October 2002
- journal article
- Published by Springer Nature in Nature Medicine
- Vol. 8 (11) , 1281-1287
Abstract
Adrenocorticotrophic hormone (ACTH)-secreting pituitary tumors are associated with high morbidity due to excess glucocorticoid production. No suitable drug therapies are currently available, and surgical excision is not invariably curative. Here we demonstrate immunoreactive expression of the nuclear hormone receptor peroxisome proliferator-activated receptor-gamma (PPAR-gamma) exclusively in normal ACTH-secreting human anterior pituitary cells: PPAR-gamma was abundantly expressed in all of six human ACTH-secreting pituitary tumors studied. PPAR-gamma activators induced G0/G1 cell-cycle arrest and apoptosis and suppressed ACTH secretion in human and murine corticotroph tumor cells. Development of murine corticotroph tumors, generated by subcutaneous injection of ACTH-secreting AtT20 cells, was prevented in four of five mice treated with the thiazolidinedione compound rosiglitazone, and ACTH and corticosterone secretion was suppressed in all treated mice. Based on these findings, thiazolidinediones may be an effective therapy for Cushing diseaseKeywords
This publication has 37 references indexed in Scilit:
- Serum cortisol response to transsphenoidal surgery for Cushing diseaseJournal of Neurosurgery, 2001
- Peroxisome Proliferator-activated Receptor γ Ligands Inhibit Retinoblastoma Phosphorylation and G1 → S Transition in Vascular Smooth Muscle CellsJournal of Biological Chemistry, 2000
- Troglitazone Suppresses Cell Growth of Myeloid Leukemia Cell Lines by Induction of p21WAF1/CIP1 Cyclin-Dependent Kinase InhibitorBiochemical and Biophysical Research Communications, 1999
- Peroxisome proliterator-activated receptors, orphans with ligands and functionsCurrent Opinion in Lipidology, 1997
- 15-Deoxy-Δ12,14-Prostaglandin J2 is a ligand for the adipocyte determination factor PPARγCell, 1995
- mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer.Genes & Development, 1994
- Transsphenoidal resection in Cushing's disease: undetectable serum cortisol as the definition of successfuI treatmentClinical Endocrinology, 1993
- Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferatorsNature, 1990
- The Use of Ketoconazole as an Inhibitor of Steroid ProductionNew England Journal of Medicine, 1987
- CUSHING'S SYNDROME?KILLING DISEASE: DISCRIMINATORY VALUE OF SIGNS AND SYMPTOMS AIDING EARLY DIAGNOSISThe Lancet, 1982